Joseph Conte
Foot & Ankle Surgery · Orlando, FLNPI 1235316043
Payments from drug & device makers
Across 36 payments — averaging $171.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reel Surgical, Inc.$2K
- Arthrex$2K
- Stryker$971
- Paragon 28, Inc.$321
- Smith+Nephew$256
- Organogenesis Inc.$126
- plus $524 from 10 others
What the payments were for
- Travel & lodging$3766%
- Food & beverage$2,19636%
- Education$3,60058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reel Surgical, Inc. | 3 | $2,426 |
| Arthrex | 3 | $1,548 |
| Stryker | 9 | $971 |
| Paragon 28, Inc. | 3 | $321 |
| Smith+Nephew | 3 | $256 |
| Organogenesis Inc. | 2 | $126 |
| Derma Sciences, Inc. | 1 | $122 |
| Treace Medical Concepts, Inc. | 1 | $100 |
| Bard Peripheral Vascular, Inc. | 1 | $77 |
| Zimmer Biomet | 1 | $55 |
| Medtronic | 1 | $54 |
| Amgen | 2 | $38 |
| Kerecis Limited | 3 | $33 |
| Integra Lifesciences Corporation | 1 | $23 |
| Mimedx Group, Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIO4$310
- AXSOS$310
- ALPHAVENT$188
- NEW PRODUCT DEVELOPMENT$170
- ALLOGRAFT$170
- SONICANCHOR$140
- NA$140
- ALLOWRAP$140
- Grafix PRIME$125
- Grafix CORE$125
- Grafix XC$125
- Grafix PL PRIME$125
- Stravix$125
- AUGMENT INJECTABLE$124
- AMNIOEXCEL$122
- TCC-EZ$122
- PRIMATRIX$122
- IDRT$122
- OMNIGRAFT$122
- v92$118
How this compares
$6,171 in reported general payments places this provider in the 65th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,344 |
| Clotrimazole | 103 | $3,268 |
| CiclopiroxCiclopirox Olamine | 43 | $1,095 |
| Ketoconazole | 28 | $655 |
| Mupirocin | 67 | $475 |
| Gabapentin | 22 | $323 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 40 | $304 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $221 |
| Methylprednisolone | 20 | $179 |
| Meloxicam | 17 | $47 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Orlando
- Thomas RoukisOrlando$1.1M
- Amber ShaneOrlando$830K
- Timothy MillerOrlando$201K
- Kiana KarbasiOrlando$94K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.